Clinical Trials
190 trialsdOCT-pBCC
Vejle Hospital
OPTIVISMO-1
University Hospital, Bordeaux
A Study Evaluating the Efficacy and Safety of Vismodegib (GDC-0449, Hedgehog Pathway Inhibitor) in Patients With Advanced Basal Cell Carcinoma
Genentech, Inc.
A Study of Vismodegib (GDC-0449) in Patients Treated With Vismodegib in a Previous Genentech-sponsored Phase I or II Cancer Study
Genentech, Inc.
Phase 2 Study Evaluating the Safety and Efficacy of Microneedle-mediated Delivery of Doxorubicin (D-MNA) in Patients With Nodular Basal Cell Carcinoma.
SkinJect, Inc.
Effectiveness and Safety of X A-DERMâ„¢ Microsurfaced Acellular Dermal Matrix for Wound Healing After MOHS Surgery
McGuire Institute
VISMONEO
University Hospital, Lille
Investigation of Mohs Surgical Margins Using Two Photon Microscopy
University of Rochester
CivaDerm(TM) Surface Therapy Pilot Study
CivaTech Oncology
NISSO
Sun Pharmaceutical Industries Limited
LegitHealth PH
AI Labs Group S.L
Intralesional Cemiplimab for Adult Patients With Cutaneous Squamous Cell Carcinoma or Basal Cell Carcinoma
Regeneron Pharmaceuticals
Using MC1R Genotype to Impact Melanoma Risk Behavior
H. Lee Moffitt Cancer Center and Research Institute
SONIB
Melanoma Institute Australia
Retreatment With Intratumoral Diffusing Alpha Radiation Emitters
Alpha Tau Medical LTD.
HPOB
Institut Curie
CASE
Regeneron Pharmaceuticals
Sonidegib in Adult Patients With Locally Advanced Basal Cell Carcinoma (laBCC) in China
Jemincare
RNA-OCT-BCC
Bispebjerg Hospital
BCC-Sonidegib
Federico II University
Open-Label Proof of Concept Study of VP-315 in Basal Cell Carcinoma
Verrica Pharmaceuticals Inc.
Laser Treatment of Basal Cell Carcinoma Under Imaging Guidance
Henry Ford Health System
Treatment Duration Increment and Pharmacodynamic Study of CX-4945 in Patients With Basal Cell Carcinoma (BCC)
Senhwa Biosciences, Inc.
H4H2-AZ
University of Arizona
Effectiveness of Narrow Margins in Patients With Low-Risk Basal Cell Carcinoma Undergoing Surgery
Thomas Jefferson University
Use of Jet-injection in Photodynamic Therapy for Basal Cell Carcinoma
Memorial Sloan Kettering Cancer Center
Photodynamic Therapy (PDT) With Metvix® 160 Milligrams/Gram Cream in Organ Transplant Participants With Non-melanoma Skin Cancer
Galderma R&D
PD-1 in Patients With Advanced Basal Cell Carcinoma Who Experienced Progression of Disease on Hedgehog Pathway Inhibitor Therapy, or Were Intolerant of Prior Hedgehog Pathway Inhibitor Therapy
Regeneron Pharmaceuticals
Investigating the Effects of Orienting Skin Grafts Parallel to Skin Tension Lines on Quality of Life in Head and Neck Located Basal Cell Carcinoma
Sifa Okulu - Independent Research Center of Dermatology and Venereology
Incidence of Melanoma and Non-melanoma Skin Cancer in People With Vitiligo
Momentum Data
NMSC
AiViva BioPharma, Inc.
DERM-SUCCESS
DermaSensor, Inc.
MS; FTY720
University of British Columbia
Vitamin D as a Nutritional Neoadjuvant During Photodynamic Therapy of Basal Cell Carcinoma
Case Comprehensive Cancer Center
CODY: A Study Evaluating The Safety And Efficacy Of QTORIN 3.9% Sirolimus Topical Gel For The Prevention Of Basal Cell Carcinomas (BCCs) In Patients With Gorlin Syndrome
Palvella Therapeutics, Inc.
PDT With Metvix 160 mg/g Cream Versus PDT With Placebo Cream in Participants With Primary Nodular Basal Call Carcinoma
Galderma R&D
Photodynamic Therapy (PDT) With Metvix Cream 160 mg/g Versus PDT With Placebo Cream in Participants With Primary Nodular Basal Cell Carcinoma
Galderma R&D
IFx-Hu2.0 for the Treatment of Patients With Skin Cancer
TuHURA Biosciences, Inc.
Study of Patidegib Topical Gel, 2%, for the Reduction of Disease Burden of Persistently Developing Basal Cell Carcinomas (BCCs) in Subjects With Basal Cell Nevus Syndrome (Gorlin Syndrome)
Sol-Gel Technologies, Ltd.
Micro3
Centre Hospitalier Universitaire de Saint Etienne
Fast Track Diagnosis of Skin Cancer by Advanced Imaging
University Hospital Bispebjerg and Frederiksberg
Reflectance Confocal Microscopy to Diagnose BCC
Skin Care Network Ltd.
Safety and Efficacy of ASN-002 Combined With a Hedgehog Pathway Inhibitor
Ascend Biopharmaceuticals Ltd
Open Label, Dose Escalation Study for the Safety and Efficacy of STP705 in Adult Patients With Basal Cell Carcinoma
Sirnaomics
Training Health Care Professional in Detecting BCC on OCT Using E-learning and CUSUM-analysis
Maastricht University Medical Center
Cancer Risk in Carriers of the Gene for Xeroderma Pigmentosum
National Institutes of Health Clinical Center (CC)
DOCTOBA
Centre Hospitalier William Morey - Chalon sur Saône
Cytodiagnosis of Basal Cell Carcinoma and Actinic Keratosis Using Papanicolaou and May-grunwald-giemsa Stained Tissue Smear
Norwegian University of Science and Technology
SmartGeneH&N
Institute of Oncology Ljubljana
Treatment of Nodular Basal Cell Carcinoma (BCC) With Imiquimod 5% Cream After Curettage
Wake Forest University Health Sciences